Chemotherapy and Biotherapy for the IR Nurse Winter 2021

February 16, 2021 to March 19, 2021

This four-day course is designed to address the needs of the nursing and other oncology professionals in relation to chemotherapy and biological therapies.  It includes information on current and investigational pharmacotherapy, safe handling, administration of antineoplastic agents, and various issues concerning the management of patients receiving cancer therapy.

Target Audience

UPMC Interventional Radiation nurses who administer antineoplastic medications

Learning Objectives

Learning Objectives

 

After participation in this activity, the learner will be able to:

  • Discuss the expectations related to class content and the participant’s professional responsibilities
  • Discuss the roles of chemotherapy and biotherapy in the treatment of cancer
  • Recall the pharmacology of different classes of antineoplastic or supportive therapies
  • Recognize side effects and organ toxicities that patients may experience while receiving antineoplastic or supportive therapies
  • Discuss management strategies for patients receiving antineoplastic or supportive therapies, including the prevention and treatment of toxicities and side effects
  • Identify interventions to prevent chemotherapy errors
  • Demonstrate that learning has occurred by achieving at least an 80% on the final exam

Additional Information

AttachmentSize
AIS- IR Nurses Chemo winter 2021.pdf99.06 KB
Course summary
Available credit: 
  • 13.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 13.00 Attendance
Course opens: 
02/15/2021
Course expires: 
04/02/2021
Event starts: 
02/16/2021 - 8:00am
Event ends: 
03/19/2021 - 5:00pm
UPMC Hillman Cancer Center
Pittsbugh, PA
United States

This course will be held virtually via UPMC Microsoft TEAMS

Amy DiMaggio, MSN, RN, CMSRN

Clinical Education Specialist

UPMC Hillman Cancer Center

Timothy George, PharmD, BCOP

Clinical Pharmacy Specialist

UPMC Hillman Cancer Center

Gloria Gotaskie, MSN, RN

Advanced Clinical Education Specialist

UPMC Hillman Cancer Center

Paul Huffman, PharmD            

Oncology Pharmacist

UPMC Hillman Cancer Center

Gerard P. Mascara, PharmD, BCOP

Clinical Oncology Pharmacist

UPMC Shadyside

Becky McClelland, MSN-Ed, RN, OCN

Clinical Education Specialist

UPMC Hillman Cancer Center

Brian Miller, PharmD

Manager, Investigational Drug Service Pharmacy

UPMC Hillman Cancer Center

Peggy Nikolajski, MSN, CRNP, AOCNP

Nurse Practitioner

UPMC Hillman Cancer Center,

St. Margaret

 

Alyssa Owens, MPAS, PA-C

Physician Assistant

UPMC Hillman Cancer Center

Brittni Prosdocimo, MSN, RN, BMTCN

Advanced Clinical Education Specialist

UPMC Hillman Cancer Center

 

 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.

This activity is designated for 13 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

The maximum number of hours awarded for this Continuing Nursing Education activity is 13 contact hours.

To receive 13 Contact Hours, the learner must sign in, attend the entire activity, pass course test with a score of 80% or greater and complete the activity evaluation.

Available Credit

  • 13.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 13.00 Attendance
Please login or register to take this course.